4CPS-147 Real world data (rwd) analysis on use of immunecheckpoint inhibitors (ici) for non-small-cell lung cancer (NSCLC) | European Journal of Hospital Pharmacy

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Section 4: Clinical pharmacy services

4CPS-147 Real world data (rwd) analysis on use of immunecheckpoint inhibitors (ici) for non-small-cell lung cancer (NSCLC)

Free

Online download statistics by month:

Online download statistics by month: March 2023 to August 2024

	Abstract	Full	Pdf
Mar 2023	24	0	5
Apr 2023	56	0	13
May 2023	33	0	9
Jun 2023	20	0	3
Jul 2023	12	0	1
Aug 2023	14	0	3
Sep 2023	10	0	4
Oct 2023	8	0	0
Nov 2023	9	0	2
Dec 2023	12	0	3
Jan 2024	5	0	0
Feb 2024	20	0	2
Mar 2024	12	0	3
Apr 2024	6	0	6
May 2024	16	0	3
Jun 2024	10	0	0
Jul 2024	8	0	4
Aug 2024	9	0	5
Total	284	0	66